Drug lookup | Fillwise

CYANOCOBALAMIN

All injection strengths: general benefit

Other products in the same Health Canada class (B03B) — coverage varies; not interchangeable

Folic acid (Folvite): general benefit, Not a benefit

Cyanocobalamin Injection USP · DIN 02413795 · 1mg/mL · injection solution-10mL Pk

General benefitDormant since 2021-06-01 · checked 2026-09-02 · What does dormant mean?

StatusGeneral benefit

Write on scriptno code needed

Patient paysPatient pays: program not supplied; amount cannot be determined.

Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.

1 brand, same coverage

Cyanocobalamin Injection USP · DIN 02413795 Manufacturer: Mylan Pharmaceuticals ULC; listing date 2015-08-26 Health Canada: Dormant since 2021-06-01 · brand CYANOCOBALAMIN INJECTION, USP · ATC B03BA01 CYANOCOBALAMIN · form Solution · route Subcutaneous, Intramuscular · ingredients VITAMIN B12 1000 MCG/ML · company Strides pharma canada inc · schedule Ethical

Check this DIN again · Health Canada product record

Cyanocobalamin Injection USP: Formulary list price $3.0600/unit (unit not stated in source; not the patient's cost)

Ministry pays: $3.0600 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=89842 · Verify on the e-Formulary ↗ (DIN 02413795)

Source record

DIN 02413795: Cyanocobalamin Injection USP Raw flags: sec3=Y, selfMed=Y Item: 880800001; group id 880; item number 2121; lccId None; manufacturer id MYL Source form: Inj Sol-10mL Pk; strength: 1mg/mL Recorded listing: General benefit; self-medication (OTC-type) product Source prices (unrounded): $3.0600; ministry $3.0600 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02413795 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=89842

Interchangeable products

Cyanocobalamin · DIN 01987003 · $3.0600 Jamp-Cyanocobalamin · DIN 02420147 · $3.0600 Rubramin · DIN 00029165 · not recorded Vitamin B12-1000mcg/mL · DIN 00521515 · $3.0600

Shortage status: active shortage (reported 2018-06-04, last updated 2018-06-05) — report may be stale, confirm; reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02413795

Shortage record checked 2026-09-13T08:10:21.292534+00:00

Health Canada lists this DIN as Dormant since 2021-06-01 — choose a marketed DIN from the same-category list.

Other drugs in the same formulary class (88:08 Vitamin B) and how they are covered

Matched class: 88:08 Vitamin B

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: LEUCOVORIN CALCIUM Some products covered without a code (check the product listing): FOLIC ACID 88:08 Vitamin B

FOLIC ACID

· 3 products · Listed, not a benefit (1), General benefit (2) · strengths: 5mg · Tab

LEUCOVORIN CALCIUM

· 4 products · General benefit · strengths: 5mg · Tab

NICOTINIC ACID

· 2 products · Listed, not a benefit · strengths: 50mg · Tab

THIAMINE HCL

· 2 products · Listed, not a benefit; DIN status E (meaning unconfirmed); confirm discontinuation/availability with Health Canada · strengths: 50mg · Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 88:08

Full class listing Related classes: 88:12 Vitamin C, 88:16 Vitamin D, 88:28 Multivitamins Same formulary class, not same indication: class membership alone does not establish equivalent uses.

What the Health Canada label says it is for

INDICATIONS AND CLINICAL USE Vitamin B12 Deficiency: For vitamin B12 deficiency occurring in pernicious anemia with or without neurological complications. Other macrocytic, megaloblastic anemias where etiology suggests malabsorption of vitamin B12 such as following: gastrectomy, gastric carcinoma, megaloblastic anemia associated with such gastrointestinal disorders as sprue syndrome, blind loops and anastomoses and fish tapeworm. Note: In macrocytic megaloblastic anemia of pregnancy and sprue syndromes, cyanocobalamin may fail to produce satisfactory response, folic acid being indicated alone or in combination with cyanocobalamin. The injection is also suitable for use as the flushing dose in the Schilling (vitamin B12 absorption) test for pernicious anemia. https://pdf.hres.ca/dpd_pm/00084630.PDF PM date: MAY 05, 2026 Source product: VITAMIN B12; DIN 00521515; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.

Availability

Cyanocobalamin Injection USP · DIN 02413795 Shortage status: active shortage (reported 2018-06-04, last updated 2018-06-05) — report may be stale, confirm; reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02413795

Check this DIN again

Health Canada: dormant products

Health Canada defines dormant products as: “products that were previously marketed in Canada but for which the manufacturer has suspended sale for period of at least 12 months.” (canada.ca, Sep 10, 2026 ↗)